Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 3/20 | 0.39 |
| ▸ | AKR1C2 | P52895 | 3/20 | 0.39 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | NPY2R | P49146 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6423698 | 0.91 | ALDH1A1 (0.39) | AKR1C3AKR1C2LMNASMN1; SMN2NOTUM | |
| SCHEMBL6425579 | 0.90 | AKR1C3 (0.38) | AKR1C3AKR1C2PLA2G7LMNASMN1; SMN2 | |
| SCHEMBL6424944 | 0.88 | AKR1C3 (0.37) | AKR1C3AKR1C2PLA2G7LMNASMN1; SMN2 | |
| SCHEMBL6423814 | 0.88 | AKR1C3 (0.39) | AKR1C3AKR1C2PLA2G7LMNASMN1; SMN2 | |
| SCHEMBL6425340 | 0.87 | MEN1 (0.36) | AKR1C3AKR1C2KMT2ACES2CES1 | |
| SCHEMBL6423338 | 0.87 | AKR1C3 (0.38) | AKR1C3AKR1C2PLA2G7LMNASMN1; SMN2 | |
| SCHEMBL6426719 | 0.86 | AKR1C3 (0.42) | AKR1C3AKR1C2PLA2G7LMNASMN1; SMN2 | |
| SCHEMBL6460948 | 0.85 | RORC (0.34) | AKR1C3AKR1C2NOTUM | |
| SCHEMBL6422809 | 0.85 | HPGD (0.34) | AKR1C3AKR1C2LMNASMN1; SMN2NOTUM | |
| SCHEMBL6422846 | 0.85 | AKR1C3 (0.43) | AKR1C3AKR1C2LMNAKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050234244-A1 | Synthesis of COX-2 and FAAH inhibitors | IRONWOOD PHARMACEUTICALS, INC. | 2005-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050234244-A1 | Synthesis of COX-2 and FAAH inhibitors | FAAH2, FAAH, PTGES2 | AKR1C3 577/4885AKR1C2 563/4885PLA2G7 33/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.